Quick answer
Extended answer
How should lyophilised and reconstituted research peptides be stored?
Key facts
- Lyophilised solid
- −20 °C, desiccated
- Reconstituted (days)
- 2–8 °C
- Reconstituted (long-term)
- −20 °C aliquots
- Container
- Low-binding vials
- Freeze-thaw
- Minimise cycles
Baseline storage principles
Peptide reference standards are sensitive to four principal stress factors: temperature, humidity, light and repeated freeze-thaw cycles. Effective storage practice controls each of these systematically rather than in isolation.
- Temperature: Cold storage slows chemical degradation. Lyophilised solids are typically held at −20 °C; long-term reconstituted stocks are also held at −20 °C in aliquots.
- Humidity: Water uptake accelerates hydrolysis. Lyophilised material should be kept desiccated and vials should be re-sealed promptly after opening.
- Light: Ultraviolet exposure can degrade aromatic residues. Store away from direct light where the peptide is known to be photosensitive.
- Mechanical stress: Avoid repeated freeze-thaw cycles and vortexing sensitive peptides; both can promote aggregation.
Storing lyophilised solids
- Hold vials at −20 °C in a dedicated peptide-storage freezer where possible.
- Keep desiccated: a sealed container or foil pouch with fresh desiccant is standard practice.
- Equilibrate to room temperature before opening to prevent atmospheric moisture condensing onto cold material.
- Record open date on the vial label; consider tracking cumulative time out of storage per SOP.
Storing reconstituted stocks
- Immediately after reconstitution, aliquot into low-binding vials sized for single use where possible.
- Label with peptide, concentration, diluent, date, batch and analyst.
- Working aliquot in daily use: 2–8 °C.
- Remaining aliquots: −20 °C, protected from light.
- Thaw each aliquot only once; discard unused material per laboratory SOP.
Container selection
- Low-binding polypropylene reduces peptide loss on plastic surfaces.
- Glass is appropriate for many peptides but may not be for all — check compound-specific documentation.
- Screw-cap vials with a suitable seal are preferred over snap-cap vials for long-term storage.
Compound-specific stability data prevails
Related procedures
- Laboratory Reconstitution Guide — from lyophilised solid to working stock.
- Retatrutide monograph — compound-specific storage detail.
Evidence summary
- What is Retatrutide?
Introductory reference on Retatrutide (LY3437943) — a triple-agonist investigational peptide referenced in incretin pharmacology literature.
- Retatrutide Mechanism of Action
Receptor-level explanation of Retatrutide's activity at GLP-1R, GIPR and GCGR as reported in the published preclinical and clinical literature.
- GLP-1 Receptor Explained
Overview of the GLP-1 receptor: a Class B G-protein-coupled receptor central to incretin pharmacology and to a growing family of research peptides.
- GIP Receptor Explained
Overview of the GIP receptor: a class B G-protein-coupled receptor engaged by dual and triple incretin-agonist research peptides.
- Glucagon Receptor Explained
Overview of the glucagon receptor (GCGR): classification, hepatic signalling and its role as the third receptor in triple-agonist research peptides.
- Triple Agonists Explained
Educational overview of triple GLP-1 / GIP / glucagon receptor agonists — pharmacological rationale, structural strategy and comparison to single- and dual-agonist analogues.
Research use only
Publication information
- Published
- 2026-07-15
- Updated
- 2026-07-15
- Reviewed
- 2026-07-15
- Version
- 1.0
Revision history
- v1.02026-07-15· Editorial Team
Initial publication as part of the Retatrutide authority cluster (Release 4.0).
Editorial standards
Content is reviewed against our editorial process for scientific accuracy, sourcing, and clarity. Read our editorial standards.
Conflict of interest
Next scheduled review: 2028-07-15. Our research methodology describes how the review is conducted.
